Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer, Richard Fox, Yuk Ma, Paul Ross, Martin James, Richard Sturgess, Clive Stubbs, Deborah Stocken, Lucy Wall, Anthony Watkinson, nigel Hacking, Jeffry Evans, Peter Collins, Richard Hubner, David Cunningham, John Primrose, Philip Johnson, Daniel Palmer
Research output: Contribution to journal › Article › peer-review
164Citations
(Scopus)
178Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial'. Together they form a unique fingerprint.